ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,560Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 1199

$1.53M Total Retail Price of All Prescriptions

Rank: 15 out of 1199

959 Patients Receiving at Least One Drug in Part D
75% Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Virginia
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

5% of this provider’s 959 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 959 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Virginia
AMLODIPINE BESYLATE 1,556 1,274 226 1 1
FUROSEMIDE 1,039 922 140 2 7
OMEPRAZOLE 905 700 172 3 5
ATORVASTATIN CALCIUM 877 724 155 4 6
LISINOPRIL 832 680 132 5 3
SIMVASTATIN 630 518 115 6 2
METOPROLOL TARTRATE 613 536 95 7 11
LEVOTHYROXINE SODIUM 591 486 86 8 4
HYDROCODONE-ACETAMINOPHEN 566 420 136 S3 9 9
HYDRALAZINE HCL 511 431 92 10 64
LOSARTAN POTASSIUM 499 407 83 11 12
NAMENDA 474 447 46 12 36
CLOPIDOGREL 471 423 58 13 20
CARVEDILOL 430 361 74 14 22
METFORMIN HCL ER 423 287 82 15 57
DIOVAN 419 355 55 16 38
TRAZODONE HCL 374 306 75 17 37
DONEPEZIL HCL 370 365* 64 18 30
METOPROLOL SUCCINATE 352 267 63 19 16
TRAMADOL HCL 332 251 97 20 18
PRAVASTATIN SODIUM 323 287 80 21 13
GABAPENTIN 323 243 63 21 15
KLOR-CON M20 322 306 49 23 48
ALLOPURINOL 321 298 56 24 34
LOVASTATIN 291 271 46 25 47
METFORMIN HCL 283 217 57 26 8
WARFARIN SODIUM 265 239 42 27 14
CLONIDINE HCL 253 167 43 28 51
HYDROCHLOROTHIAZIDE 232 137 40 29 10
VALSARTAN-HYDROCHLOROTHIAZIDE 207 163 33 30 70
MIRTAZAPINE 203 190 44 31 52
LEVETIRACETAM 203 138 31 31 83
PREDNISONE 193 169 61 33 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 193 155 33 33 33
POTASSIUM CHLORIDE 188 163 43 35 19
ALPRAZOLAM 181 112 43 B 36 21
MONTELUKAST SODIUM 178 116 33 37 42
QUETIAPINE FUMARATE 175 148 29 A 38 45
POLYETHYLENE GLYCOL 3350 170 147 56 39 71
NIFEDICAL XL 169 141 23 40 227
PROAIR HFA 165 65 61 41 44
TAMSULOSIN HCL 162 157* 36 42 27
BD ULTRA-FINE PEN NEEDLE 158 92 47 43 122
PANTOPRAZOLE SODIUM 151 98 30 44 24
CIPROFLOXACIN HCL 151 122 120 44 69
RISPERIDONE 151 137 27 A 44 75
HALOPERIDOL 150 145* 18 A 47 179
OXYBUTYNIN CHLORIDE ER 146 133 18 48 144
BUMETANIDE 145 126 24 49 93
FINASTERIDE 144 130 25 50 89
LACTULOSE 141 122 18 51 102
JANUVIA 141 105 24 51 67
SERTRALINE HCL 140 118 25 53 23
ADVAIR DISKUS 138 111 39 54 59
ATENOLOL 137 109 20 55 17
TAMIFLU 137 126 132 55 366
XARELTO 135 111 16 57 202
NIFEDIPINE ER 134 122 18 58 118
CITALOPRAM HBR 131 102 26 59 25
LANTUS SOLOSTAR 131 72 36 59 79
LOSARTAN-HYDROCHLOROTHIAZIDE 127 69 28 61 39
ISOSORBIDE MONONITRATE ER 124 110 18 62 53
LANTUS 115 110* 24 63 60
NOVOLOG 112 107* 33 64 115
PAROXETINE HCL 110 71 17 65 68
SPIRIVA 105 77 22 66 63
TRADJENTA 97 92* 16 67 287
NEXIUM 95 76 23 68 32
HUMALOG MIX 75-25 94 68 26 69 264
EXFORGE HCT 92 71 15 70 363
OXYCODONE-ACETAMINOPHEN 91 52 29 S2 71 66
NOVOLOG MIX 70-30 89 84* 16 72 247
CRESTOR 89 63 25 72 31
LORAZEPAM 86 64 36 B 74 26
VERAPAMIL ER 80 80 12 75 112
AMOX TR-POTASSIUM CLAVULANATE 80 56 67 75 134
AGGRENOX 78 73* 12 77 157
NAPROXEN 78 61 30 77 113
ALBUTEROL SULFATE 76 71* 33 79 111
EXFORGE 74 39 11 80 212
FLUTICASONE PROPIONATE 74 40 37 80 29
LATANOPROST 74 69* 11 80 169
BACLOFEN 73 <11 <11 83 98
DILTIAZEM ER 70 <11 <11 84 229
GLIPIZIDE ER 69 64* 11 85 100
TRIAMTERENE-HCTZ 69 <11 <11 85 62
FAMOTIDINE* 69 53 12 85 74
PROMETHAZINE HCL 68 37 26 R 88 104
CYMBALTA 67 62* 12 89 54
NYSTATIN 67 62* 36 89 128
NOVOLOG FLEXPEN 67 53 19 89 129
CYCLOBENZAPRINE HCL 66 34 24 R 92 85
TRIAMCINOLONE ACETONIDE 66 47 39 92 125
HUMALOG 66 61* 20 92 96
GLIPIZIDE 66 61* 14 92 50
ESCITALOPRAM OXALATE 64 48 17 96 49
SPIRONOLACTONE 63 48 17 97 61
NASONEX 62 47 30 98 211
RANITIDINE HCL 61 40 11 99 41
PHENYTOIN SODIUM EXTENDED 60 <11 <11 100 148
AMLODIPINE BESYLATE-BENAZEPRIL 59 <11 <11 101 77
ALENDRONATE SODIUM 58 53* 11 102 43
AMIODARONE HCL 57 52* 12 103 174
DOXAZOSIN MESYLATE 55 <11 <11 104 88
NOVOLOG MIX 70-30 FLEXPEN 54 27 13 105 195
FLOVENT HFA 53 35 15 106 388
INSULIN SYRINGE* 52 38 16 107 150
IBUPROFEN 51 35 16 108 78
OXYBUTYNIN CHLORIDE 51 <11 <11 108 160
OLANZAPINE 50 45* 11 A 110 137
VIMPAT 50 <11 <11 110 355
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.